For citations:
Eschalier R., McMurray J., Swedberg K., Veldhuisen van D., Krum H., Pocock S., Shi H., Vincent J., Rossignol P., Zannad F., Pitt B. SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE). Rational Pharmacotherapy in Cardiology. 2014;10(1):106-115. (In Russ.) https://doi.org/10.20996/1819-6446-2014-10-1-106-115
Email this article 